Athlet Museum Bolzen annkristin heine Vorwort Kaufmann Schmelze
Team | IMMEI
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Team | IMMEI
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
Loop | Annkristin Heine
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Team | IMMEI
Caspase-3 activity is increased significantly upon treatment with Syk... | Download Scientific Diagram
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Café Kinderwagen: ein Angebot für Groß und Klein | Spökenkieker - Ihr regionales Anzeigenmagazin
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
ImmunoSensation / The Immune Sensory System » Details
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
PDF) G-quadruplexes: a promising target for cancer therapy
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
PDF) Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
UKB NewsRoom | Annkristin Heine
Implementing combinatorial immunotherapeutic regimens against cancer
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
CIO Bonn - Lymphomzentrum
ImmunoSensation / The Immune Sensory System » Details
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell